lasofoxifene — Topline data
H2 2027
The Company expects to complete enrollment of ~600 participants in the Phase 3 ELAINE-3 clinical trial in the fourth quarter of 2026 and to have topline data in the second half of 2027.Source filing
LONA biotech catalysts & pipeline
LEONABIO INC · Data as of 2026-09-08